Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoride treatments for arrest and prevention of dental caries in primary teeth
ACTRN12616000007437Phase 3Completed
- Sponsor
- University of Tasmania
- Start
- Feb 2017
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of silver diamine fluoride, Potassium iodide and sodium fluoride in carious lesion (4 arms), sponsored by University of Tasmania. Primary endpoints: Dental caries arrest and Dental caries prevention. Started Feb 2017; status: completed.
02
Drugs
silver diamine fluoridePotassium iodidesodium fluoride
03
Conditions
carious lesion
Beyond the preview
Go deeper on ACTRN12616000007437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000007437.